The PREDICT Study: The PREterm Delivery In Twins StudyEffectiveness of vaginally administered progesterone to prevent preterm delivery in twin pregnancies – A multicentre randomized trial - PREDICT

Rigshospitalet, Ultrasound Clinic 40230 个研究点目标入组 750 人开始时间: 2006年5月15日最近更新: 2014年3月10日

适应症

试验速览

暂无简介。

•1) Twin pregnancy
•2) Informed consent
•3) 18-23 weeks’ gestation
•4) Participants must be able to speak and understand the language spoken in the respective centres
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1) Age < 18 years
•2) Known allergy to progesterone or peanuts
•3) Active thromboembolic disorders or a history of hormone-associated thromboembolic disorders
•4) Rupture of membranes at the time of inclusion
•5) Monoamniotic twins
•6) Pregnancies treated for or with signs of twin-to-twin transfusion syndrome at inclusion
•7) Multiple pregnancies reduced to twin pregnancies
•8) Known significant structural or chromosomal fetal abnormality
•9) Chorionicity not assessed before 15 weeks
•10) Known or suspected malignancy in genitals or breasts
•11) Known liver disease

发起方

Rigshospitalet, Ultrasound Clinic 4023